A novel method could test for prostate cancer using biomarkers present in urine, according to the findings from a diagnostic case control study.
Clinicians typically classify meningiomas—the most common type of brain tumor—into three grades, ranging from slow-growing to aggressive. But a new multi-institutional study suggests that appearances may be deceiving. If a tumor shows activity in a gene called telomerase reverse transcriptase, it tends to recur more quickly, even if it looks low-grade under the microscope.
